Haben sie von Salesforce ALS-Con-201 Dumps von EchteFrage gehört? Aber, Haben Sie diese Dumps benutzt? Viele Leute haben gesagt, dass EchteFrage Dumps sehr gute Unterlagen sind, womit sie die Salesforce ALS-Con-201 Zertifizierungsprüfung bestanden haben. Wir EchteFrage sind von vielen Leuten, die früher die Salesforce ALS-Con-201 Dumps benutzt haben, gut bewertet, weil sie wirklich viel Zeit für die Salesforce ALS-Con-201 Prüfungen sparen und den Erfolg für die Teilnehmer garantieren.
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Solution Design and Configuration | 25% | - Design Agentforce solutions for Life Sciences scenarios - Implement Agentforce AI agents for clinical trial support - Build automation flows for compliance workflows - Design integration with external Life Sciences systems - Configure Salesforce Health Cloud for Life Sciences |
| Topic 2: Life Sciences Industry Overview and Salesforce Agentforce for Life Sciences | 15% | - Describe how Agentforce applies to Life Sciences use cases - Explain key regulatory compliance requirements (FDA, GxP, HIPAA) - Understand Life Sciences industry processes (pharmaceutical, biotech, medical device) |
| Topic 3: Discovery and Requirements Gathering | 20% | - Identify stakeholder requirements for Life Sciences implementations - Map business processes to Salesforce Agentforce capabilities - Assess data quality and integration needs - Document functional and technical requirements |
| Topic 4: Testing, Deployment, and Enablement | 20% | - Deploy Agentforce solutions following validation requirements - Develop training materials for Life Sciences users - Create documentation for regulated environments - Plan and execute testing strategies for Life Sciences solutions - Establish support processes for post-production compliance |
| Topic 5: Compliance and Security | 20% | - Apply Field Audit Trail for regulated data - Configure audit trails and tracking for FDA requirements - Set up data partitioning for multi-tenant pharmaceutical environments - Implement data security for HIPAA compliance |
>> Salesforce ALS-Con-201 PDF Demo <<
Die neuesten Schulungsunterlagen zur Salesforce ALS-Con-201 (Salesforce Certified Agentforce Life Sciences Consultant) Zertifizierungsprüfung von EchteFrage sind von den Expertenteams bearbeitet, die vielen beim Verwirklichen ihres Traums verhelfen. In der konkurrenzfähigen Gesellschaft muss man die Fachleute seine eigenen Kenntinisse und Technikniveau unter Beweis stellen, um seine Position zu verstärken. Durch die Salesforce ALS-Con-201 Zertifizierungsprüfung kann man seine Fähigkeiten beweisen. Mit dem Salesforce ALS-Con-201 Zertifikat werden große Veränderungen in Ihrer Arbeit stattfinden. Ihr Gehalt wird erhöht und Sie werden sicher befördert.
97. Frage
Choose 1 option.
Cumulus Pharma wants to roll out Tableau Next to provide its field sales team with real-time performance insights, such as "Visit Plan Attainment," directly within the Agentforce Life Sciences mobile app. The relevant Metrics have been created, the Tableau View component has been added to the Mobile Home Page Lightning record page, and the metadata cache has been refreshed. However, when a field sales rep logs in to the app, the Metrics component displays an error indicating insufficient privileges and the metrics do not load.
Which Tableau Next permission set should the Agentforce Life Sciences Consultant assign to resolve this issue?
Antwort: C
Begründung:
The correct answer is C because field sales reps only need to view and consume Tableau Next metrics in the Life Sciences mobile app. Salesforce Help for Tableau Next in Life Sciences Cloud explains that Tableau Next integrates with Life Sciences Cloud to provide actionable insights and enhanced visualizations. Salesforce's Tableau Next permission guidance also identifies Tableau Next Consumer as the permission set used for viewing Tableau Next content and interacting with metrics, while creator-level access is intended for users who create and manage Tableau Next assets.
In this scenario, the technical setup has already been completed: the metrics exist, the Tableau View component has been placed on the Mobile Home Page Lightning record page, and the mobile metadata cache has been refreshed. The remaining issue is an insufficient-privileges error, which indicates that the user lacks the Tableau Next permissions required to load and consume the metric. Assigning Tableau Next Consumer grants the field rep the appropriate access level without giving unnecessary authoring privileges.
Option A, Tableau Next Creator, is incorrect because field sales reps are not creating or administering metrics; they only need to consume them. Option B, CRM Analytics Plus User, is also incorrect because the requirement is specifically for Tableau Next metrics, not legacy CRM Analytics access. Therefore, the consultant should assign the Tableau Next Consumer permission set.
=========
98. Frage
Choose 1 option.
The intake team at Cumulus Pharma handles Healthcare Provider (HCP) consent forms by fax and email. The operations manager needs a report to analyze the volume of documents based on whether they were "Incoming" or "Outgoing" to HCPs. The report must filter based on the direction of the document flow using standard fields.
Which field on the Received Document object should an Agentforce Life Sciences Consultant recommend for grouping this report?
Antwort: B
Begründung:
The correct answer is B because the standard field that represents whether a received document is incoming or outgoing is Direction. Salesforce's Life Sciences Cloud Developer Guide for the ReceivedDocument object lists direction values such as INCOMING - Incoming and OUTGOING - Outgoing, which directly matches the reporting requirement in the scenario.
The operations manager wants to analyze document volume based on whether consent forms are flowing into the organization from HCPs or being sent out to HCPs. That is a directional reporting requirement, not a document lifecycle or status requirement. Grouping the report by the Direction field allows the team to separate inbound consent forms from outbound documents using standard Salesforce data rather than creating a custom field or relying on interpretation.
Option A, Flow Type, is incorrect because the question is not asking about a business process type, document-processing flow, or automation path. It specifically asks for whether the document was incoming or outgoing. Option C, Document Status, is also incorrect because status would indicate where the document is in its lifecycle, such as received, processed, pending, or completed depending on configuration. Status does not define the direction of the document exchange. Therefore, the consultant should recommend grouping and filtering the report by the standard Direction field on Received Document.
=========
99. Frage
Choose 1 option.
Cumulus Pharma wants to track email interactions and in-person visits as two distinct types of interactions. The system should count these separately to ensure field sales reps meet their target of six emails and three visits. The solution must use standard Activity Plan configuration objects to categorize these interactions based on the Visit Channel.
Which object defines these distinct interaction categories?
Antwort: B
Begründung:
Option A is correct because Provider Activity Measure Type defines how engagement activities are measured and categorized in Activity Plans. Salesforce Help explains that an activity can be an interaction with a healthcare professional, such as a visit, and that a channel is the medium in which the interaction or activity occurs. This is exactly the requirement: Cumulus Pharma wants to distinguish email interactions from in-person visits so each channel can be counted separately against the field rep's targets.
Salesforce Help for creating Activity Plans also states that admins should verify that a provider activity measure type has been created to track provider engagement activities. This confirms that Provider Activity Measure Type is the setup object used to define what kind of activity is being measured.
Option B, Provider Activity Goal, is not correct because it represents the target or goal assigned to providers or reps, such as six emails or three visits. It does not define the activity category itself. Option C, Provider Activity Plan Interaction, is also not the best answer because the question asks which configuration object defines the distinct interaction categories. The measure type is the categorization layer that can use Visit Channel, such as Email or In-Person, to count interactions separately. Therefore, Provider Activity Measure Type is the correct answer.
=========
100. Frage
Choose 1 option.
Cumulus Pharma has configured and activated a new agent using the Life Sciences Field Sales template. However, when a field sales rep attempts to use the agent to generate a summary for a targeted Healthcare Provider (HCP), they are unable to access the feature. Reps must have the privileges required to interact with these capabilities.
Which permission set should the Agentforce Life Sciences Consultant assign to grant access to these Agentforce features?
Antwort: C
Begründung:
Option C is correct because Salesforce Help identifies "Access Life Sciences Customer Engagement Agentforce" as the permission required for Life Sciences Customer Engagement Agentforce capabilities. In the Salesforce Help reference for the Life Sciences "Generate Healthcare Provider Summary" action, Salesforce lists the required access as Access Life Sciences Customer Engagement Agentforce. It also notes that, to run flows associated with agent actions, users need the Run Flows app permission or access to the individual flows.
This directly matches the scenario. The Life Sciences Field Sales agent template has already been configured and activated, but the field sales rep cannot use the agent-generated HCP summary capability. That means the issue is not the existence of the agent or the template; it is the user's permission to access the Life Sciences Customer Engagement Agentforce features. Salesforce's Account Summarization permissions documentation also references Access Life Sciences Customer Engagement Agentforce as part of the permission setup for account summarization, alongside standard Life Sciences user permission sets.
Option A, Life Sciences Commercial User, is not specific enough to grant access to these Agentforce capabilities. Option B, Agentforce Service Agent User, relates to Agentforce service use cases and is not the Life Sciences Customer Engagement permission named in the documentation. Therefore, the consultant should assign Access Life Sciences Customer Engagement Agentforce.
101. Frage
Choose 1 option.
At Cumulus Pharma, field sales reps report that the Next Best Action component is not visible on the account profile, even though the recommendation data is confirmed to be loaded and synced to mobile.
What is the cause of this issue?
Antwort: A
Begründung:
Option B is correct because Life Sciences Cloud for Customer Engagement uses Life Sciences-specific Next Best components for the mobile and account-profile experience. Salesforce's Life Sciences Next Best documentation explains that Next Best Action suggests timely actions such as visits and emails, and the Life Sciences Customer Engagement data model includes Life Sciences-specific recommendation objects such as Territory Account Recommended Action, Territory Account Product Message Score, and Territory Account Score. These are not the same as the generic Einstein Next Best Action component and strategy experience.
The question states that the recommendation data is already loaded and synced to mobile. That removes the most likely data-load or synchronization issue. If the data exists but the component is not visible on the account profile, the issue is most likely the wrong component placement. The page must use the Life Sciences Next Best Action component that is designed to render Life Sciences recommendations in the Life Sciences mobile app.
Option A is not the best answer because inactive strategy logic would generally prevent recommendations from being generated or returned, but the scenario confirms the recommendation data is present. Option C is also less likely because a permission problem would typically prevent access to the recommendation records or data, not specifically indicate that the component itself was configured incorrectly. Therefore, the consultant should replace the generic Einstein Next Best Action component with the Life Sciences Next Best Action component.
=========
102. Frage
......
EchteFrage zusammengestellt Salesforce ALS-Con-201 mit Original-Prüfungsfragen und präzise Antworten, wie sie in der eigentlichen Prüfung erscheinen. Eine der Tatsachen Sicherstellung einer hohen Qualität der Salesforce Certified Agentforce Life Sciences Consultant-Prüfung ist die ständig und regelmäßig zu aktualisieren. EchteFrage ernennt nur die besten und kompetentesten Autoren für ihre Produkte und die Prüfung EchteFrage ALS-Con-201 zum Zeitpunkt des Kaufs ist absoluter Erfolg.
ALS-Con-201 Demotesten: https://www.echtefrage.top/ALS-Con-201-deutsch-pruefungen.html